The AmnioPUR is a multipurpose, chorion-free, cyropressed allograft that is derived from the amniotic membrane. It provides a structural matrix for filling bone voids and soft tissue that is anti-microbial and anti-inflammatory.
More Articles on Supply Chain:
NuVasive Q3 Income at $7k, Up Nearly 250% From Last Year
ArthroCare Profits Increase 4.27% in Q3
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
